Table 3

Percentages of CCM measures, IENFD, NCS, quantitative sensory testing, and cardiovascular autonomic nerve function tests below the 2.5th or above the 97.5th percentile limit of normal in the diabetic and control groups studied

Diabetic group, % (95% CI)Control group, % (95% CI)P value
CNFL18.6 (12.0–26.9)4.2 (0.8–12.5)0.019
CNFL-MNF17.4 (11.1–25.6)6.3 (1.7–15.4)0.111
CNFD5.8 (2.3–11.8)00.160
CNFD-MNF20.9 (14.0–29.4)6.3 (1.7–15.4)0.027
CNBD4.7 (1.6–10.3)00.296
CNBD-MNF17.4 (11.1–25.6)4.2 (0.8–12.5)0.031
CNCP4.7 (1.6–10.3)00.296
CNCP-MNF00
IENFD13.7 (7.6–22.1)00.013
Peroneal motor NCV31.4 (23.2–40.6)2.3 (0.1–10.6)<0.001
Sural sensory NCV35.7 (27.0–45.2)0<0.001
Sural SNAP24.1 (16.6–33.1)0<0.001
Malleolar VPT30.6 (22.4–39.8)0<0.001
Warm TDT foot9.3 (4.7–16.2)00.052
Cold TDT foot26.7 (19.0–35.7)2.4 (0.1–10.8)0.001
CV at rest14.3 (8.2–22.5)10.0 (3.5–21.4)0.575
CV during deep breathing14.3 (8.2–22.5)4.9 (0.9–14.6)0.215
  • CV, coefficient of R-R interval variation.